bioMérieux S.A. (EPA:BIM)
France · Delayed Price · Currency is EUR 119.10
+0.70 (0.59%)
Jul 22, 2025, 5:35 PM CET
bioMérieux Revenue
In the year 2024, bioMérieux had annual revenue of 3.98B EUR with 8.31% growth. bioMérieux had revenue of 2.08B in the half year ending December 31, 2024, with 7.61% growth.
Revenue
3.98B
Revenue Growth
+8.31%
P/S Ratio
3.51
Revenue / Employee
275.41K
Employees
14,754
Market Cap
13.96B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 26.51B |
| Sanofi | 45.17B |
| Sartorius Stedim Biotech | 2.86B |
| Eurofins Scientific SE | 6.95B |
| Ipsen | 3.57B |
| Virbac | 1.40B |
| Clariane SE | 5.28B |
| emeis Société anonyme | 5.64B |
bioMérieux News
- 4 months ago - bioMérieux S.A. (BMXMF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 11 months ago - bioMérieux S.A. (BMXMF) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 years ago - bioMérieux S.A. (BMXMF) CEO Alexandre Mérieux on Q4 2021 Results - Earnings Call Transcript - Seeking Alpha
- 4 years ago - bioMérieux S.A. (BMXMF) CEO Alexandre Mérieux on Q3 2021 Results - Earnings Call Transcript - Seeking Alpha
- 4 years ago - bioMérieux: Pioneering In Vitro Diagnostics - Seeking Alpha
- 4 years ago - bioMérieux S.A. (BMXMF) CEO Alexandre Mérieux on Q4 2020 Results - Earnings Call Transcript - Seeking Alpha